Back

Marinus Pharmaceuticals Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Sell

MRNS
Marinus Pharmaceuticals

Last Price:

1.52

Seasonality Move:

-0.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Marinus Pharmaceuticals Price Quote

$1.52

+0.01 (+4.83%)

(Updated: May 4, 2024 at 6:28 AM ET)

Marinus Pharmaceuticals Key Stats

Sell

Marinus Pharmaceuticals (MRNS) is a Sell

Day range:

$1.48 - $1.65

52-week range:

$1.11 - $11.26

Dividend yield:

P/E ratio:

0.00

P/S ratio:

2.62

P/B ratio:

4.95%

Volume:

1.6M

Avg. volume:

3.4M

1-year change:

-83.22%

Market cap:

$82.9M

Revenue:

$31M

EPS:

$-2.63

How Much Does Marinus Pharmaceuticals Make?

How Much Are Marinus Pharmaceuticals's Sales Annually?
MRNS Revenues are $31M
How Much Profit Does Marinus Pharmaceuticals's Make A Year?
MRNS net income is -$141.4M

Is Marinus Pharmaceuticals Growing As A Company?

What Is Marinus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0%
What Is Marinus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Marinus Pharmaceuticals Stock Price Performance

Did Marinus Pharmaceuticals Stock Go Up Last Month?
Marinus Pharmaceuticals share price went down by -82.64% last month
Did MRNS's Share Price Rise Over The Last Year?
MRNS share price fell by -83.22% over the past 1 year

What Is Marinus Pharmaceuticals 52-Week High & Low?

What Is Marinus Pharmaceuticals’s 52-Week High Share Price?
Marinus Pharmaceuticals has traded as high as $11.26 over the past 52 weeks
What Is Marinus Pharmaceuticals’s 52-Week Low Share Price?
Marinus Pharmaceuticals has traded as low as $1.11 over the past 52 weeks

Marinus Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Marinus Pharmaceuticals?

How Much Debt Does Marinus Pharmaceuticals Have?
Total long term debt quarterly is $73M
How Much Cash Does Marinus Pharmaceuticals Have?
Cash and short term investments quarterly total is $150.3M
What Is Marinus Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.31

Is Marinus Pharmaceuticals Cash Flow Positive?

What Is MRNS Cash Flow From Operations?
Cash flow from operations (TTM) is -$118M
What Is Marinus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.6M
What Is Marinus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$28.6M

Marinus Pharmaceuticals Return On Invested Capital

Is Management Doing A Good Job?
MRNS return on invested capital is -102.32%
What Is Marinus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -66.75%
What Is MRNS Return On Equity?
ROE is a measure of profitability and is -214.43%

Marinus Pharmaceuticals Earnings Date & Stock Price

What Is Marinus Pharmaceuticals's Stock Price Today?
A single share of MRNS can be purchased today for 1.51
What Is Marinus Pharmaceuticals’s Stock Symbol?
Marinus Pharmaceuticals trades on the nasdaq under the ticker symbol: MRNS
When Is Marinus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Marinus Pharmaceuticals is scheduled on May 10, 2024
When Is MRNS's next ex-dividend date?
Marinus Pharmaceuticals's next ex-dividend date is May 6, 2024
How To Buy Marinus Pharmaceuticals Stock?
You can buy Marinus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Marinus Pharmaceuticals Competitors

Who Are Marinus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Marinus Pharmaceuticals or are related in some way:
- ADMA Biologics Inc (ADMA)
- Actinium Pharmaceuticals Inc (ATNM)
- Ligand Pharmaceuticals Inc (LGND)
- Macrogenics Inc (MGNX)
- Soligenix Inc (SNGX)

Marinus Pharmaceuticals Dividend Yield